Early post-transplantation hypophosphatemia is associated with elevated FGF-23 levels

European Journal of Endocrinology

Volumn 164, Issue 5, 2011, Pages 839-847

  Trombetti, Andrea ^a   Richert, Laura ^a   Hadaya, Karine ^a   Graf, Jean Daniel ^a   Herrmann, François R ^a   Ferrari, Serge L ^a   Martin, Pierre Yves ^a   Rizzoli, René ^a  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; CALCITRIOL; CALCIUM; CARBOXY TERMINAL TELOPEPTIDE; FIBROBLAST GROWTH FACTOR 23; GLUCOCORTICOID; GROWTH FACTOR RECEPTOR; PAMIDRONIC ACID; PARATHYROID HORMONE; PHOSPHATE; VITAMIN D; BIOLOGICAL MARKER; FIBROBLAST GROWTH FACTOR;

ADULT; ARTICLE; DIETARY INTAKE; FEMALE; HUMAN; HYPOPHOSPHATEMIA; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; KIDNEY TUBULE ABSORPTION; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; PHOSPHATE BLOOD LEVEL; PHOSPHATE METABOLISM; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; VITAMIN BLOOD LEVEL; BLOOD; COMPARATIVE STUDY; GRAFT REJECTION; MIDDLE AGED; PHYSIOLOGY; POSTOPERATIVE COMPLICATION; TIME; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; FOLLOW UP; GLOMERULUS FILTRATION RATE; POSTOPERATIVE PERIOD;

BIOLOGICAL MARKERS; FEMALE; FIBROBLAST GROWTH FACTORS; GRAFT REJECTION; HUMANS; HYPOPHOSPHATEMIA; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 79955456863     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-10-1150     Document Type: Article

References (37)

1. Ambuhl PM, Meier D,Wolf B, Dydak U, Boesiger P & Binswanger U. Metabolic aspects of phosphate replacement therapy for hypophosphatemia after renal transplantation: impact on muscular phosphate content, mineral metabolism, and acid/base homeostasis. American Journal of Kidney Diseases 1999 34 875-883. (doi:10.1016/S0272-6386(99)70045-4)
2. Ghanekar H, Welch BJ, Moe OW & Sakhaee K. Post-renal transplantation hypophosphatemia: a review and novel insights. Current Opinion in Nephrology and Hypertension 2006 15 97-104. (doi:10.1097/01.mnh.0000203187.49890.cc)
3. Felsenfeld AJ, Gutman RA, Drezner M & Llach F. Hypophosphatemia in long-term renal transplant recipients: effects on bone histology and 1,25-dihydroxycholecalciferol. Mineral and Electrolyte Metabolism 1986 12 333-341. (Pubitemid 17002640)
4. Green J, Debby H, Lederer E, Levi M, Zajicek HK & Bick T. Evidence for a PTH-independent humoral mechanism in post-transplant hypophosphatemia and phosphaturia. Kidney International 2001 60 1182-1196. (doi:10.1046/j.1523-1755. 2001.0600031182.x)
5. Parfitt AM, Kleerekoper M & Cruz C. Reduced phosphate reabsorption unrelated to parathyroid hormone after renal transplantation: implications for the pathogenesis of hyperparathyroidismin chronic renal failure. Mineral and Electrolyte Metabolism 1986 12 356-362. (Pubitemid 17002644)
6. Rosenbaum RW, Hruska KA, Korkor A, Anderson C & Slatopolsky E. Decreased phosphate reabsorption after renal transplantation: evidence for a mechanism independent of calcium and parathyroid hormone. Kidney International 1981 19 568-578. (doi:10.1038/ki.1981.54)
7. Graf H, Kovarik J, Stummvoll HK, Wolf A & Pinggera WF. Handling of phosphate by the transplanted kidney. Proceedings of the European Dialysis and Transplant Association 1979 16 624-629.
8. Evenepoel P, Naesens M, Claes K, Kuypers D & Vanrenterghem Y. Tertiary 'hyperphosphatoninism' accentuates hypophosphatemia and suppresses calcitriol levels in renal transplant recipients. American Journal of Transplantation 2007 7 1193-1200. (doi:10.1111/j.1600-6143.2007.01753.x)
9. Bhan I, Shah A, Holmes J, Isakova T, Gutierrez O, Burnett SM, Juppner H & Wolf M. Post-transplant hypophosphatemia: tertiary 'hyper- phosphatoninism'?Kidney International2006701486-1494. (doi:10.1038/sj.ki. 5001788)
10. Pande S, Ritter CS, Rothstein M, Wiesen K, Vassiliadis J, Kumar R, Schiavi SC, Slatapolsky E & Brown AJ. FGF-23 and sFRP-4 in chronic kidney disease and post-renal transplantation. Nephron. Physiology 2006 104 p23-p32. (doi:10.1159/000093277)
11. Ferrari SL, Bonjour JP & Rizzoli R. Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men. Journal of Clinical Endocrinology and Metabolism 2005 90 1519-1524. (doi:10.1210/jc.2004-1039)
12. Marks J, Debnam ES & Unwin RJ. Phosphate homeostasis and the renal - gastrointestinal axis. American Journal of Physiology. Renal Physiology 2010 299 F285-F296. (doi:10.1152/ajprenal.00508.2009)
13. Yamazaki Y, Okazaki R, Shibata M, Hasegawa Y, Satoh K, Tajima T, Takeuchi Y, Fujita T, Nakahara K, Yamashita T & Fukumoto S. Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia. Journal of Clinical Endocrinology and Metabolism 2002 87 4957-4960. (doi:10.1210/jc.2002-021105)
14. Bushinsky DA & Monk RD. Electrolyte quintet: calcium. Lancet 1998 352 306-311. (doi:10.1016/S0140-6736(97)12331-5)
15. Bijvoet OL, Morgan DB & Fourman P. The assessment of phosphate reabsorption. Clinica Chimica Acta 1969 26 15-24. (doi:10.1016/0009-8981(69) 90280-0)
16. Buchs B, Rizzoli R & Bonjour JP. Evaluation of bone resorption and renal tubular reabsorption of calcium and phosphate in malignant and nonmalignant hypercalcemia. Bone 1991 12 47-56. (doi:10.1016/8756-3282(91)90055- N)
17. Levi M. Post-transplant hypophosphatemia. Kidney International 2001 59 2377-2387. (doi:10.1046/j.1523-1755.2001.00755.x)
18. Sakhaee K. Post-renal transplantation hypophosphatemia. Pediatric Nephrology 2009 25 213-220. (doi:10.1007/s00467-009-1252-4)
19. Economidou D, Dovas S, Papagianni A, Pateinakis P & Memmos D. FGF-23 levels before and after renal transplantation. Journal of Transplantation 2009 2009 379082. (doi:10.1155/2009/379082)
20. Herdman RC, Michael AF, Vernier RL, Kelly WD & Good RA. Renal function and phosphorus excretion after human renal homotransplantation. Lancet 1966 1 121-123. (doi:10.1016/S0140-6736(66)91260-8)
21. Bacchetta J, Dubourg L, Harambat J, Ranchin B, Abou-Jaoude P, Arnaud S, Carlier MC, Richard M & Cochat P. The influence of glomerular filtration rate and age on fibroblast growth factor 23 serum levels in pediatric chronic kidney disease. Journal of Clinical Endocrinology and Metabolism 2010 95 1741-1748. (doi:10.1210/jc.2009-1576)
22. Juppner H,Wolf M & Salusky IB. FGF-23: more than a regulator of renal phosphate handling? Journal of Bone and Mineral Research 2010 25 2091-2097. (doi:10.1002/jbmr.170)
23. Mirams M, Robinson BG, Mason RS & Nelson AE. Bone as a source of FGF23: regulation by phosphate? Bone 2004 35 1192-1199. (doi:10.1016/j.bone. 2004.06.014)
24. Levi M, Shayman JA, Abe A, Gross SK, McCluer RH, Biber J, Murer H, Lotscher M & Cronin RE. Dexamethasone modulates rat renal brush border membrane phosphate transporter mRNA and protein abundance and glycosphingolipid composition. Journal of Clinical Investigation 1995 96 207-216. (doi:10.1172/JCI118022)
25. Loffing J, Lotscher M, Kaissling B, Biber J, Murer H, Seikaly M, Alpern RJ, Levi M, Baum M & Moe OW. Renal Na/H exchanger NHE-3 and Na-PO4 cotransporter NaPi-2 protein expression in glucocorticoid excess and deficient states. Journal of the American Society of Nephrology 1998 9 1560-1567.
26. Rude RK & Singer FR. Magnesium deficiency and excess. Annual Review of Medicine 1981 32 245-259. (doi:10.1146/annurev.me.32.020181.001333)
27. Burnett SM, Gunawardene SC, Bringhurst FR, Juppner H, Lee H & Finkelstein JS. Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women. Journal of Bone and Mineral Research 2006 21 1187-1196. (doi:10.1359/jbmr.060507)
28. Antoniucci DM, Yamashita T & Portale AA. Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men. Journal of Clinical Endocrinology and Metabolism 2006 91 3144-3149. (doi:10.1210/jc.2006- 0021)
29. 3 and phosphorus in vivo. Journal of Biological Chemistry 2005 280 2543-2549. (doi:10.1074/jbc.M408903200)
30. 3 production. Journal of Biological Chemistry 2003 278 2206-2211. (doi:10.1074/jbc.M207872200)
31. Sato T, Fukagawa M, Uchida K, Katayama A, Nagasaka T, Matsuoka S, Goto N, Tominaga Y, Kobayashi T & Nakao A. 1,25-Dihydroxyvitamin D synthesis after renal transplantation: the role of fibroblast growth factor 23 and cyclosporine. Clinical Transplantation 2009 23 368-374. (doi:10.1111/j.1399-0012.2009.00995. x)
32. Quarles LD. FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization. American Journal of Physiology. Endocrinology and Metabolism 2003 285 E1-E9. (doi:10.1152/ajpendo.00016.2003)
33. Brown WW, Juppner H, Langman CB, Price H, Farrow EG, White KE & McCormick KL. Hypophosphatemia with elevations in serum fibroblast growth factor 23 in a child with Jansen's metaphyseal chondrodysplasia. Journal of Clinical Endocrinology and Metabolism 2009 94 17-20. (doi:10.1210/jc.2008-0220)
34. Rhee Y, Farrow E, Lee R, Bivi N, Lezcano V, Plotkin L, White K & Bellido T. FGF23 gene expression is upregulated by PTH receptor activation in osteocytes in vitro and in vivo: a parathyroid-bone link influencing the endocrine function of osteocytes. Journal of Bone and Mineral Research 2009 24 (Supplement 1) Available at http://www.asbmr.org/Meetings/AnnualMeeting/. A09001860.
35. Evenepoel P, Meijers BK, de Jonge H, Naesens M, Bammens B, Claes K, Kuypers D & Vanrenterghem Y. Recovery of hyperphosphatoninism and renal phosphorus wasting one year after successful renal transplantation. Clinical Journal of the American Society of Nephrology 2008 3 1829-1836. (doi:10.2215/CJN.01310308)
36. Riminucci M, Collins MT, Fedarko NS, Cherman N, Corsi A, White KE,Waguespack S, Gupta A, Hannon T, Econs MJ, Bianco P & Gehron Robey P. FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting. Journal of Clinical Investigation 2003 112 683-692. (Pubitemid 38057709)
37. Samadfam R, Richard C, Nguyen-Yamamoto L, Bolivar I & Goltzman D. Bone formation regulates circulating concentrations of fibroblast growth factor23. Endocrinology 20091504835-4845. (doi:10.1210/en.2009-0472)